Wang W K, Essex M, McLane M F, Mayer K H, Hsieh C C, Brumblay H G, Seage G, Lee T H
Department of Cancer Biology, Harvard School of Public Health, Boston, MA 02115, USA.
Proc Natl Acad Sci U S A. 1996 Jun 25;93(13):6693-7. doi: 10.1073/pnas.93.13.6693.
Differential rates of AIDS development and/or T4 lymphocyte depletion in HIV-1-infected individuals remain unexplained. The hypothesis that qualitative differences in selection pressure in vivo may account for different rates of disease progression was addressed in nine eligible study participants from a cohort of 315 homosexual men who have been followed since 1985. Disproportionately fewer changes in variable regions and more in C3 of gp12O were found to be significantly associated with slower disease progression. Our finding provides the first example to demonstrate that differential selection pressure related to the emergence of HIV-1 variants is associated with long term nonprogression. Candidate vaccines that elicit strong selection pressure on C3 of gp120 are likely to provide better protection than those targeting variable regions.
HIV-1感染个体中艾滋病发展和/或T4淋巴细胞耗竭的不同速率仍无法解释。自1985年以来对一个由315名同性恋男性组成的队列进行随访,在9名符合条件的研究参与者中探讨了体内选择压力的质量差异可能导致疾病进展速率不同这一假说。结果发现,gp120可变区变化相对较少而C3区变化较多与疾病进展较慢显著相关。我们的发现首次证明,与HIV-1变异体出现相关的差异选择压力与长期不进展有关。对gp120的C3区产生强烈选择压力的候选疫苗可能比针对可变区的疫苗提供更好的保护。